Hot Findings in Aging Research

  • Home /
  • General Public /
  • Hot Findings

7 results

Research Centers Collaborative Network (RCCN)

The problems associated with an aging society transcend the boundaries of any specific discipline and play out across multiple biologic and societal domains ranging from individual cells, to organs and organ systems, to persons, to communities, to national and world economies. The six National Institute on Aging (NIA) Center programs address important topics in aging but typically from a specific disciplinary perspective.

The objective of the Research Centers Collaborative Network (RCCN) is to initiate new cross-disciplinary collaborative networks that bring together key thought leaders from each of the six NIA center programs to align approaches across programs that will uncover synergies and insights that lead to novel collaborations.

  • October 11, 2018
Posted on October 11, 2018

Workshop on Synergies Between Alzheimers Research and Clinical Gerontology and Geriatrics: Current Status and Future Directions

Age is the strongest risk factor for physical disability and Alzheimers disease (AD) and related dementias. As such, other aging-related risk factors are also shared by these two health conditions. However, clinical geriatrics and gerontology research has included cognition and depression in models of physical disability, with less attention to the pathophysiology of neurodegenerative disease. Similarly, AD research generally incorporates limited, if any, measures of physical function and mobility, and therefore often fails to consider the relevance of functional limitations in neurodegeneration.

Posted on October 10, 2018

PREPARE for Your Care helps you make informed decisions and get the care that is right for you.

PREPARE is a step-by-step program with video stories to help you have a voice in YOUR medical care, talk with your doctors, and give your family and friends peace of mind.

  • January 1, 2018
Posted on October 9, 2018

Discovery and Validation of Agonistic Angiotensin Receptor Autoantibodies as Biomarkers of Adverse Outcomes

Agonistic angiotensin II type 1 receptor autoantibodies (AT1RaAbs) have not been associated with functional measures or risk for adverse health outcomes. AT1RaAbs could be used to stratify patient risk and to identify patients who can benefit from angiotensin receptor blocker treatment.

Posted on March 1, 2018

University of Florida College of Medicine - Online Graduate Programs in Gerontology

Online Gerontology Graduate Program - Americans are living longer than ever, and life expectancy is currently at a record high. More than 10,000 baby boomers turn 65 every day, and according to the Eldercare Workforce Alliance, the United States is ill-prepared to meet current and future workforce needs for its aging adult population.

  • November 30, 2016
Posted on January 1, 2018

6th Vital Sign Measuring Mobile Health Join the global study. Improve the health of the world.

The 6th Vital Sign is a global research study that uses Apple’s ResearchKit to measure a vital sign. Vital signs, like blood pressure or temperature, are measurements used by doctors and nurses to see how healthy a person is.

  • November 30, 2016
Posted on January 1, 2018